Status | Study |
Not yet recruiting |
Study Name: Daratumumab in Treatment of PGNIMD and C3 GN Condition: Membranoproliferative Glomerulonephritis Date: 2017-03-20 Interventions: Drug: Daratumumab Open-label Other Name: Darzalex |
Recruiting |
Study Name: Unravel MGUS (Monoclonal Gammopathy of Unknown Significance) Condition: Monoclonal Gammopathy of Unknown Significance Date: 2016-09-15 Interventions: Other: Blood sample taken Other: Answering |
Not yet recruiting |
Study Name: Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat Condition: Monoclonal Gammopathies Overweight Date: 2016-08-22 Interventions: Drug: Liraglutide Interventional, single-group, open label pilot study. The investigators will identify |
Recruiting |
Study Name: A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early Condition: Plasma Cell Dyscrasia Monoclonal Gammopathy Date: 2016-04-11 |
Recruiting |
Study Name: Prospective Observational Study of Clinical and Genomic Predictors of Progression to Myeloma in Asymptomatic Monoclonal Gammopathies Condition: Monoclonal Gammopathy of Unknown Significance Smoldering Multip Date: 2016-03-30 Interventions: Procedure: Blood Collection Blood (about 1-2 tablespoons) collected for biomarker and routine tests and |
Enrolling by invitation |
Study Name: B-Cell Hematologic Malignancy Vaccination Registry Condition: Monoclonal Gammopathy of Undetermined Significance Multiple Mye Date: 2014-11-20 |
Recruiting |
Study Name: Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome Condition: Monoclonal Gammopathy of Undetermined Significance (MGUS) Chron Date: 2014-10-09 |
Completed |
Study Name: Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma Condition: Monoclonal Gammopathy of Undetermined Significance Smoldering M Date: 2013-09-23 Interventions: Behavioral: Relaxation Response Resiliency Program (3RP) The intervention will consist of one intake wit |
Withdrawn |
Study Name: Imaging Studies and the Development of Multiple Myeloma Condition: Multiple Myeloma Smoldering Multiple Myeloma Date: 2012-04-04 Interventions: Drug: Fluciclatide 7mCi |
Completed |
Study Name: Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy Condition: Monoclonal Gammopathy Monoclonal Gammopat Date: 2011-08-23 Interventions: Other: blood and bone marrow samples Specific tests of the |